Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor
Clinical trial NCT06996093 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06996093
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-02
- Primary completion
- 2030-06-01
- Enrollment
- 2508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.